Many insurance companies require documentation of BMI, diagnosis, medical necessity, and previous weight-loss attempts
Strong evidence should include improved recipient-cell bioenergetics, tracking of donor-specific mitochondrial DNA or proteins, ultrastructural or high-resolution live-cell confirmation, loss-of-function experiments, and functional rescue [31,32,33,34,35]
The honest cautions: much of the mechanistic depth still comes from animal models, we need longer and larger human trials, and allulose can cause bloating or loose stools at higher doses, as most poorly absorbed sugars can
Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database
We expected that patients taking the GLP-1s for obesity may have a lower cost of care and improved medical outcomes as we presumed that the weight loss could have led to a decrease in the frequency of office/hospital visits and/or the use of drugs for treatment of conditions such as hypertension, high cholesterol and osteoarthritis